Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

    Published: August 1, 2010 | Price: $3,995.00 – $7,990.00

    Vaccines have been one of the faster growing areas of the pharmaceutical industry, and during a troubling series of years, they have been the superstars of many companies' portfolios. They've also attracted the attention of insurance companies, retail outlets and the media. The global market for vaccines experienced strong growth through 2009 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Kalorama Information has been...
    World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)

    Published: March 1, 2012 | Price: $3,995.00 – $7,990.00

    This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describing the global market and identifying major market factors that may help to shape the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and acquisitions in the industry, and this report takes those updated details into account in...
    The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

    Published: March 15, 2012 | Price: $3,995.00 – $7,990.00

    The advancing age of the population makes long-term care an important consideration for health marketers.  This report, The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis: Nursing care; Home care; Hospice care; Assisted living. Kalorama Information publishes its fourth edition of this detailed report on the...
    The Market for Home Care Products, 7th Edition (Wheelchairs, Oxygen Products, Disposable Infusion Pumps, Home Ventilators, Incontinence Supplies, Defibrillators and Other Products)

    Published: April 6, 2012 | Price: $3,995.00 – $7,990.00

    This report, The Market for Home Care Products, 7th. Edition covers the market for products specially designed to assist with regular tasks of daily living.  Growth in the ambulatory aids market continues to be driven by several key trends including the aging U.S. population, new product introductions and relatively generous government reimbursement programs, despite recent modifications. As part of its market analysis, this report includes the following information: Current U.S. Market Size Estimates and Forecasts to 2016 Market Forecast to...
    The World Market for Over The Counter (OTC) Drugs

    Published: May 7, 2012 | Price: $3,995.00 – $7,990.00

    Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription.  Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs. OTC drugs are sold to consumers by convenience and grocery stores. However, new technology has allowed a new range of outlets including online sales and catalog. Drugs included in OTC segments are pain relievers, cough and cold remedies, sleeping aids, antifungals, and...
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition

    Published: May 11, 2012 | Price: $3,995.00 – $7,990.00

    The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery...
    What’s Next In Vaccines (Malaria, Diabetes, Alzheimer’s, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)

    Published: June 5, 2012 | Price: $3,995.00 – $7,990.00

    Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines? examines and estimates the market for vaccines that have yet to be launched.    What diseases may see a prophylactics vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can...
    Advanced Remote and Wireless Patient Monitoring Markets, 5th Edition

    Published: July 5, 2012 | Price: $3,995.00 – $7,990.00

    Advanced patient monitoring devices have wireless or remote monitoring features allowing them to share data outside the immediate patient care area continue to see sales growth. Features on these devices can range from basic remote tracking ability to “face-to-face” interaction between clinicians and patients, or even data sorting of the vast amount of data collected in order to put it into the context of a patient’s condition. Many systems now transfer data to an electronic medical record (EMR), and some...
    Medical Imaging Markets: Contrast Agents (X-Ray, CT, Ultrasound, MRI, PET, SPECT)

    Published: July 9, 2012 | Price: $3,995.00 – $7,990.00

    Today’s capabilities in clinical diagnostic radiology have been made possible by advances not only in diagnostic systems, but also by the contrast media and radiopharmaceuticals that make it possible to see, in great detail, the body’s internal structures, organs and tissue that would nototherwise be clearly seen. Although bones are readily apparent on radiographic images, other organs and tissues are not. These imaging agents may be usedduring a medical imaging procedure to highlight specific parts of the body andmake them...
    Hospital Acquired Infections: Testing Markets

    Published: August 14, 2012 | Price: $3,995.00 – $7,990.00

    A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). The following are among the hospital infections considered in this report: Acinetobacter Baumannii Clostridium Difficile Hospital-Acquired Pneumonia Pseudomonas Aeruginosa...
    Early Toxicology: Markets and Approaches

    Published: September 12, 2012 | Price: $3,995.00 – $7,990.00

    Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET. Toxicity determinations are an integral part of all aspects of drug discovery & development. This report, Early Toxicology Markets and Approaches, focuses on markets for early toxicology testing services. The objective of this report is to focus the reader’s attention on the issues and opportunities related...
    Medical Imaging Markets: Molecular Imaging

    Published: September 26, 2012 | Price: $3,995.00 – $7,990.00

    Molecular imaging techniques include nuclear medicine imaging – positron emission tomography (PET) and single photon emission computed tomography (SPECT) and combination PET/CT and SPECT/CT techniques – as well as ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) imaging that are used with molecular imaging agents. Molecular imaging has evolved into a pillar of molecular medicine. It combines functional imaging with structural imaging so that specific in-vivo molecular processes can be identified and spatially pinpointed, often with the use of...
    World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 5th Edition, The

    Published: October 10, 2012 | Price: $3,995.00 – $7,990.00

    This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and Semi-elemental, Specialized for Chronically Ill Patients) Parenteral Nutrition For each category, the report provides revenue data and forecasts for the most important segmentations. The report includes incidence of conditions which often require enteral or parenteral feeding, birth rates,...
    Kalorama Vaccine Market Research Report Bundle (Vaccines 2012, What’s Next in Vaccines, Vaccine Production Markets)

    Published: October 18, 2012 | Price: $3,995.00 – $7,990.00

    Vaccines are an important part of the business model of top pharmaceutical companies. The success of several recent vaccine product introductions has been of great interest to pharma R&D efforts. The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth in many categories through 2011, declines in others, and this is expected to continue through the forecast period. Growth is being fueled...
    The World Market for Stents (Drug-Eluting and Bare Metal Product Markets in US, EU, Japan, India, China and ROW)

    Published: October 26, 2012 | Price: $3,995.00 – $7,990.00

    The coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and has a longer life expectancy, the prevalence of coronary heart disease and co-morbid conditions such as hypertension, diabetes and obesity is projected to rise and stimulate the demand for coronary stents. Additionally, a growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing...